loader from loading.io

In the News.. BG trends during COVID lockdowns, diabetes sales fraud, A Dexcom G5 message, and more!

Diabetes Connections | Type 1 Diabetes

Release Date: 09/17/2021

In the News... top diabetes stories and headlines happening now! show art In the News... top diabetes stories and headlines happening now!

Diabetes Connections | Type 1 Diabetes

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: kids' A1C and tech access correlation, first generic GLP-1 for weight loss approved, Metformin cuts long covid risk, Tandem Diabetes & Eversense updates, and more! Find out more about  Please visit our Sponsors & Partners - they help make the show possible! Learn more about   from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Here's where to find us: Learn more about...

info_outline
From the WNBA and NBA, Diabetes Legends Lauren Cox and Gary Forbes share their stories show art From the WNBA and NBA, Diabetes Legends Lauren Cox and Gary Forbes share their stories

Diabetes Connections | Type 1 Diabetes

Lauren Cox and Gary Forbes both live with type 1 diabetes and both played at the very highest level of the sport: the WNBA and the NBA. Podcaster Rob Howe brought them together as part of the Diabetes Legends Basketball Clinic – an ongoing event for kids and teenagers with type 1 that takes place in different cities around the country. I sat down with all three of them to talk about what it takes to get to that level of pro sports with type 1, what setbacks they had along the way, what keeps them going, and advice they have for families today.  This episode was recorded live at the...

info_outline
When it’s even more than T1D: Stacy’s fight for health & hope show art When it’s even more than T1D: Stacy’s fight for health & hope

Diabetes Connections | Type 1 Diabetes

This week on Diabetes Connections.. when T1D is one of many chronic conditions. Stacy Abrams was diagnosed with type 1 at age five, and she’s faced a slew of other issues since then. Chronic fatigue, celiac, a long road to uncovering mold and environmental illness. She shares the highs and lows of that journey, what helped along the way, and why having a medical team that truly listens makes all the difference. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Join us at  Learn more about  Please visit...

info_outline
In the News.. CRISPR transplant for type 1, T1D risk if dad has type 2, Metformin and the brain, oral GLP-1, and more! show art In the News.. CRISPR transplant for type 1, T1D risk if dad has type 2, Metformin and the brain, oral GLP-1, and more!

Diabetes Connections | Type 1 Diabetes

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: CRISPR modified cell transplant for type 1, risk of T1D if parent has a different type of diabetes, Metformin and the brain, oral GLP-1, and more! Find out more about  Please visit our Sponsors & Partners - they help make the show possible! Learn more about   from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Here's where to find us: Learn more about everything at our...

info_outline
Why this endo is pushing for a diabetes drug you've probably never heard of (and the FDA has rejected). show art Why this endo is pushing for a diabetes drug you've probably never heard of (and the FDA has rejected).

Diabetes Connections | Type 1 Diabetes

We've got an important update on a diabetes drug you may have never heard about. Sotagliflozin is known to have big benefits for people with type 2 but getting it approved for type 1 has been frustrating to say the least. The FDA has twice declined to approve it for people with T1D, but experts – including my guest – are pushing and hoping that will soon change. I’m talking to Dr. Steve Edleman, an endocrinologist who lives with type 1 and heads up the group We’ll talk about the risks that come with sotogliflozin, how continuous ketone monitoring could change the game, and what you...

info_outline
Ask Me Anything: Unfiltered Wisdom from Natalie Bellini and Julia Blanchette, two healthcare providers who live with type 1 diabetes show art Ask Me Anything: Unfiltered Wisdom from Natalie Bellini and Julia Blanchette, two healthcare providers who live with type 1 diabetes

Diabetes Connections | Type 1 Diabetes

We've got a funny, informative, helpful and no holds barred “Ask Me Anything” panels. Recorded at Moms’ Night Out in Cleveland, you’ll hear from two incredible experts who’ve lived with type 1 diabetes for decades—Julia Blanchette, PhD, RN, CDCES, and Natalie Bellini, DNP, FNP-BC, CDCES. We tackle everything from helping grandparents understand modern T1D care, to balancing diabetes in a marriage, to managing ADHD alongside diabetes in teens. We’ll also dig into why screening for type 1 is so important—and how to find the community and resources that make life with diabetes...

info_outline
In the News... GLP-1 oral pill moves forward, Medtronic-Abbott sensor unveiled, Afrezza submitted for kids, diabetes scholarships and more! show art In the News... GLP-1 oral pill moves forward, Medtronic-Abbott sensor unveiled, Afrezza submitted for kids, diabetes scholarships and more!

Diabetes Connections | Type 1 Diabetes

 It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: cancer reserach may lead to T1D treatment, GLP-1 oral pill moves forward, Tandem pharmacy moves, Medtronic-Abbott sensor unveield, parents of kids with T1D see income drop, Mannkind submits Afrezza for pediatrics, diabetes scholarships and more! Find out more about  Please visit our Sponsors & Partners - they help make the show possible! Learn more about   from extreme temperatures The best way to keep up with Stacey and the show is by...

info_outline
Ketones: preventing DKA now and hope for the future of monitoring show art Ketones: preventing DKA now and hope for the future of monitoring

Diabetes Connections | Type 1 Diabetes

We’re all supposed to know about ketones, but how much education did you actually get?   I’m talking to Dr. Jennifer Sherr, a pediatric endocrinologist who lives with type 1 about the basics of ketones and a lot more. She shares best practices to stay safe, what most people with diabetes really do and what she’s hopeful for in terms of making ketone monitoring easier. We’ve been managing T1D for 18 plus years and I was surprised, there was still a lot here I didn’t know.   This podcast is not intended as medical advice. If you have those kinds of questions, please...

info_outline
Peloton’s Robin Arzón on T1D Screening  Plus: The Science Behind Tzield show art Peloton’s Robin Arzón on T1D Screening Plus: The Science Behind Tzield

Diabetes Connections | Type 1 Diabetes

We're diving into the first-ever treatment that can delay the onset of type 1 diabetes—Tzield—and hearing from two powerful voices helping spread the word about screening. First, Peloton star Robin Arzon shares her personal journey - managing diabetes through marathons, pregnancy, and parenting—and why she believes time and information are two of the most valuable tools in diabetes care. Robin is VP of Fitness Programming and Head Instructor at Peloton, 27x marathoner, Swagger Society Founder, best-selling author, and Sanofi spokesperson We're also going to learn more about Tzield itself...

info_outline
In the News.. A new insulin approved, DOJ rules on CGM in schools, T2D artificial sweetener study, and more! show art In the News.. A new insulin approved, DOJ rules on CGM in schools, T2D artificial sweetener study, and more!

Diabetes Connections | Type 1 Diabetes

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: FDA approves the first fast-acting biosimilar insulin in the US, Tandem issues warning, DOJ stands up for remote monitoring in schools, GLP1 use protects against dementia, and more! Find out more about  Please visit our Sponsors & Partners - they help make the show possible! Learn more about   from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Here's where to find us: Learn...

info_outline
 
More Episodes

It's In the News... the top diabetes stories of the past seven days! This week, what did lockdown mean for BG trends, Provention Bio keeps fighting for Teplizumab, the FTC shuts down diabetes schlockmeisters and if you're still using the Dexcom G5 - you need to hear this...

Join Stacey live on Facebook each Wednesday at 4:30pm EDT to watch live.

Check out Stacey's book: The World's Worst Diabetes Mom!

Join the Diabetes Connections Facebook Group!

Sign up for our newsletter here

-----

Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!
-----

Get the App and listen to Diabetes Connections wherever you go!

Click here for iPhone      Click here for Android

Episode transcription and links below

Hello and welcome to Diabetes Connections In the News! I’m Stacey Simms and these are the top diabetes stories and headlines of the past seven days.  As always, I’m going to link up my sources in the Facebook comments – where we are live – and in the show notes at d-c dot com when this airs as a podcast.. so you can read more if you want, on your own schedule.

XX

In the News is brought to you by Real Good Foods! Find their Entrée Bowls and all of their great products in your local grocery store, Target or Costco.

XX

Our top story.. What did COVID lockdown mean for blood sugar trends? A new study says when they had to stay at home, people with type 1 significantly improved while the opposite happened for those with type 2.

You should know these studies all come from European countries with pretty strict lockdowns and they’re an aggregate – a look at a bunch of previously conducted studies.

With type 1, time in range improved significantly in 83% of the studies looked at here.. with type 2, almost half of the studies showed a clear decrease in blood sugar control, with higher A1Cs.

So what happened? There’s a lot of speculation but these researchers suggest less exercise and more snacking and more stress is to blame for the type 2 numbers..  although in my opinion the same could be said for all people with diabetes. They also suppose that the lockdown gave parents more time to look after kids with type 1 and gave young adults a more predictable routine.

I hope another study is done on this in the US where, frankly – access to insulin & health care providers may have become more of an issue during the pandemic

https://www.news-medical.net/news/20210913/COVID-19-lockdown-linked-to-improved-glycemic-control-in-type-1-diabetes.aspx

XX

Bit of an update - Provention Bio moving forward to answer the FDA’s questions and hopefully resubmit. This is for Teplizumab the first drug shown to prevent type 1 diabetes for – so far- up to three years.. although the FDA turned it down in July.

Provention says they continue to collect data and are moving to set up what’s called a Formal Type A meeting to submit that new information.

The company’s CEO says they believe they’re making significant progress to address the observations cited by the FDA and continue to work with urgency.

 

https://finance.yahoo.com/news/provention-bio-provides-potential-timing-113000253.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr

 

XX

Bunch of schlock-meisters got called out last week by the US FDA and FTC – that’s the Federal Trade Commission. 10 companies got warning letters alleging they were selling illegal dietary supplements to cure or prevent diabetes. Regulators wrote the products cited in the warning letters are considered unapproved new drugs – they include things like turmeric, bitter melon, ginkgo biloba and more.. The report cites the increasing cost of insulin and other diabetes medications as a reason why people are turning to alternatives, even if they aren’t proven.. Please.. be careful out there.

https://www.naturalproductsinsider.com/supplements/regulators-target-diabetes-supplements-recent-warnings-about-claims

 

Quick additional FTC note – they held a virtual open meeting today. Two people from the diabetes community spoke about rising insulin prices. If you’d like to learn more I’ll link up the information.

https://www.ftc.gov/news-events/press-releases/2021/09/ftc-announces-tentative-agenda-september-15-open-commission

XX

We don’t talk a lot about shots – multiple daily injections – but here’s some good news about the basics. New study shows rotating sites and using smaller needles really do help. You’ve likely heard of LY-po-hy-PER-tro-fee.. it’s when lumps of fat or scar tissue form under your skin. These Belgian researchers did a six month study where they provided smaller pen needles and did a lot of education, including an online platform where they taught proper injection techniques, including not re-using needles. They reduced what they called unexplained high blood glucose significantly and glucose variability decreased as well. A1Cs stayed about the same.

https://onlinelibrary.wiley.com/doi/10.1111/dme.14672

XX

No surprise but still disappointing –  insurance is what’s dictating whether young children are more likely to use a CGM regularly. This was published in Diabetes Technology & Therapeutics.

Those on public or government insurance often face more obstacles.

This was a study of children ages 1-6 years, within two months of diagnosis.

82-percent used a CGM at least once during the study period.. but they divided everyone into 4 groups – always used CGM, stable use, inconsistent use or never used.

Families with private insurance were more likely to be in the always group or the stable group than those with public insurance. And..

The “always” group had an A1C that was 1.3% lower than the “never” group

https://www.healio.com/news/endocrinology/20210907/private-insurance-determines-cgm-use-by-young-children-with-type-1-diabetes

XX

More to come, including a Dexcom G5 update! But first, I want to tell you about one of our great sponsors who helps make Diabetes Connections possible.

Real Good Foods. Where the mission is Be Real Good

They make nutritious foods— grain free, high in protein, never added sugar and from real ingredients—the new Entrée bowls are great. They have a chicken burrito, a cauliflower mash and braised beef bowl.. the lemon chicken I’ve told you about and more! They keep adding to the menu line! You can buy online or find a store near you with their locator right on the website. I’ll put a link in the FB comments and as always at d-c dot com.

Back to the news…

Heads up if you’re still – somehow – using the Dexcom G5. More than a year ago, Dexcom stopped selling the G5 and G4.. but – and thanks to the listeners who brought this to my attention – the G5 app is now sending out a notification.. On October 4th the Dexcom G5 app will no longer be available. As they’ve shared with us on the podcast many times, they’ve been transitioning everyone over to the G6 and will soon move on to the G7. No timeline on that btw I know you’re going to ask. But as far as we know, it hasn’t been submitted to the FDA and Dexcom has said it will go for European approval first.

--

And finally don’t forget to send me your Dear Dr. Banting audio! What would you say to the man credited with the discovery of insulin? All the details and how to send it to me is in the show notes.

--

Please join me wherever you get podcasts for our next episode - The episode out right now is all about the new Walmart Insulin.. will it save you money?

That’s In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon.